FDA.reportPublic FDA data

12 HR fostemsavir 600 MG Extended Release Oral Tablet

RxCUI
2380549
RxNorm name
12 HR fostemsavir 600 MG Extended Release Oral Tablet
Display name
12 HR fostemsavir 600 MG Extended Release Oral Tablet
Full name
12 HR fostemsavir 600 MG Extended Release Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:11

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
a21006b7-6d6f-4f06-81b4-17978756452b12 HR fostemsavir 600 MG Extended Release Oral TabletSCD8These highlights do not include all the information needed to use RUKOBIA safely and effectively. See full prescribing information for RUKOBIA. RUKOBIA (fostemsavir) extended-release tablets, for oral use Initial U.S. Approval: 202020240213
a21006b7-6d6f-4f06-81b4-17978756452bfostemsavir 600 MG 12HR Extended Release Oral TabletPSN8These highlights do not include all the information needed to use RUKOBIA safely and effectively. See full prescribing information for RUKOBIA. RUKOBIA (fostemsavir) extended-release tablets, for oral use Initial U.S. Approval: 202020240213
a21006b7-6d6f-4f06-81b4-17978756452b12 HR fostemsavir 600 MG (equivalent to 725 MG fostemsavir tromethamine) Extended Release Oral TabletSY8These highlights do not include all the information needed to use RUKOBIA safely and effectively. See full prescribing information for RUKOBIA. RUKOBIA (fostemsavir) extended-release tablets, for oral use Initial U.S. Approval: 202020240213
a21006b7-6d6f-4f06-81b4-17978756452bfostemsavir 600 MG 12 HR Extended Release Oral TabletSY8These highlights do not include all the information needed to use RUKOBIA safely and effectively. See full prescribing information for RUKOBIA. RUKOBIA (fostemsavir) extended-release tablets, for oral use Initial U.S. Approval: 202020240213